PMC:7156291 / 12092-12507 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"233","span":{"begin":56,"end":64},"obj":"Species"},{"id":"234","span":{"begin":35,"end":52},"obj":"Disease"},{"id":"235","span":{"begin":70,"end":78},"obj":"Disease"}],"attributes":[{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"Tax:9606"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"MESH:D008171"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Evolution of CT characteristics of pulmonary lesions in patients with COVID-19. The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95). GGO, ground glass opacities; mixed attenuation = ground glass opacities + consolidation"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":70,"end":78},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Evolution of CT characteristics of pulmonary lesions in patients with COVID-19. The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95). GGO, ground glass opacities; mixed attenuation = ground glass opacities + consolidation"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T67","span":{"begin":186,"end":189},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T68","span":{"begin":262,"end":264},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Evolution of CT characteristics of pulmonary lesions in patients with COVID-19. The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95). GGO, ground glass opacities; mixed attenuation = ground glass opacities + consolidation"}

{"project":"LitCovid-sentences","denotations":[{"id":"T130","span":{"begin":80,"end":327},"obj":"Sentence"},{"id":"T131","span":{"begin":328,"end":415},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Evolution of CT characteristics of pulmonary lesions in patients with COVID-19. The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95). GGO, ground glass opacities; mixed attenuation = ground glass opacities + consolidation"}